Alembic Pharma expands US footprint with $12 million acquisition of Utility Therapeutics

Alembic Pharmaceuticals aims to commercialise Utility’s FDA-approved and pipeline products in the US market.

Leave a Reply

Your email address will not be published. Required fields are marked *